Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
Timothy A. Yap
, David J. Kwiatkowski
, Ibiayi Dagogo-Jack
, Michael Offin
, Marjorie G. Zauderer
,
Robert Kratzke
, Jayesh Desai
, Amy Body
, Michael Millward
, Anthony W. Tolcher
, Kanwal P.S. Raghav
, Archie Thurston
, Len Post
, F. Andrew Dorr
, Tracy T. Tang
, Yufeng Li
, Neelesh Sharma
, Hedy L. Kindler
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
100%
Mesothelioma
100%
Creatinine
33%
Proteinuria
33%
Albumin
33%
Tumor Growth
16%
Orphan Drug
16%
Progression Free Survival
16%
Peripheral Edema
16%
Diseases
16%